Dr Michael J Friedman, DO | |
100 Century Pkwy Ste 350, Mount Laurel, NJ 08054-1149 | |
(856) 482-9000 | |
(856) 482-1159 |
Full Name | Dr Michael J Friedman |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 100 Century Pkwy Ste 350, Mount Laurel, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104897586 | NPI | - | NPPES |
7729103 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MB06319800 (New Jersey) | Primary |
Entity Name | Rowansom Dept Of Psychiatry |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689644122 PECOS PAC ID: 4486647708 Enrollment ID: O20040405000333 |
News Archive
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of the University of Twente.
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.
Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.
› Verified 8 days ago
Entity Name | Cumberland County Guidance Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447337134 PECOS PAC ID: 0345280814 Enrollment ID: O20050504000986 |
News Archive
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of the University of Twente.
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.
Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.
› Verified 8 days ago
Entity Name | Oaks Integrated Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255427647 PECOS PAC ID: 6709961857 Enrollment ID: O20080313000127 |
News Archive
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of the University of Twente.
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.
Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.
› Verified 8 days ago
Entity Name | Virtua Medical Group, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of the University of Twente.
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.
Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael J Friedman, DO 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054-1149 Ph: (856) 482-9000 | Dr Michael J Friedman, DO 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054-1149 Ph: (856) 482-9000 |
News Archive
The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.
Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of the University of Twente.
Mississippi State University has been awarded a $10 million grant for five years of support from the National Institutes of Health to further research focusing on diseases that affect animal and human health.
Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.
› Verified 8 days ago
Maria C Carta, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 25 Lexington Ct, Mount Laurel, NJ 08054 Phone: 609-567-6042 Fax: 609-567-2722 | |
Dr. Luke Hansen, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054 Phone: 856-482-9000 | |
Dr. Helen H. Yi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054 Phone: 856-482-9000 Fax: 856-482-1159 | |
Salvatore Montana Messina, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054 Phone: 856-482-9000 Fax: 856-482-1159 | |
Dr. James J. Rogers, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 Century Pkwy Ste 350, Mount Laurel, NJ 08054 Phone: 856-482-9000 Fax: 856-482-1159 | |
Olga Mora-aldrich, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1120 Route 73 Ste 300, Mount Laurel, NJ 08054 Phone: 800-442-8938 |